Vulvar cancer natural history

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] Syed Musadiq Ali M.B.B.S.[3]


Vulvar cancer Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vulvar cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vulvar cancer natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vulvar cancer natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vulvar cancer natural history

CDC on Vulvar cancer natural history

Vulvar cancer natural history in the news

Blogs on Vulvar cancer natural history

Directions to Hospitals Treating Vulvar cancer

Risk calculators and risk factors for Vulvar cancer natural history

Overview

If left untreated, patients with vulvar cancer may progress to develop ulcer on vulva or wart-like patches on vulva and chronic pruritus of the vulva. Common complications of vulvar cancer include fistula and metastasis. Prognosis is generally good, and the 5 year survival rate of patients with vulvar cancer is approximately 71.2%.

Natural history

  • Patient has early symptoms like ulcer on vulva, chronic pruritus of the vulva, and wart-like patches on vulva.[1]
  • As the tumor grows larger, patient may notice symptoms like unusual bleeding or discharge from the lesion, large mass on the vulva, dysuria, and dyspareunia.
  • In advanced disease, metastases may be present in the abdomen and lungs.
  • The patient may present with dyspnea, cough with blood-stained sputum, persistent pain or discomfort in the chest, edema hands/feet, and inguinal lymphadenopathy.
  • Once the cancer spreads to the other organs, it is most likely fatal.[2]

Complications

Common complications of valvular cancer include:[3][4]

Prognosis

Stage 5-year relative survival (%)
I 93%
II 79%
III 53%
IV 29%

References

  1. Sykes P, Eva L, van der Griend R, McNally O, Blomfield P, Brand A, Tristram A, Bergzoll C, Petrich S, Kenwright D, Payne K, Kellow M, Innes C, Harker D, Perrin L, Cohen P, Jaaback K, Simcock B (February 2019). "Pathological process has a crucial role in sentinel node biopsy for vulvar cancer". Gynecol. Oncol. doi:10.1016/j.ygyno.2019.02.012. PMID 30814024.
  2. Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J (January 2017). "Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology". J Natl Compr Canc Netw. 15 (1): 92–120. PMID 28040721.
  3. Dass PH, Kuper-Hommel MJ (November 2017). "A review of squamous cell vulvar cancers in Waikato region, New Zealand". N. Z. Med. J. 130 (1465): 19–28. PMID 29121621.
  4. Wiggans A, Coleridge S, Bryant A, Morrison J (April 2019). "Relationship between vulvar symptoms and incidence of vulvar cancer in women referred to a rapid access clinic". Int J Gynaecol Obstet. doi:10.1002/ijgo.12818. PMID 30932169.
  5. Survival statistics for vulvar cancer. Vulvar cancer. http://www.cancer.ca/en/cancer-information/cancer-type/vulvar/prognosis-and-survival/survival-statistics/?region=ns Accessed on October 1, 2015